Unique ID issued by UMIN | UMIN000046308 |
---|---|
Receipt number | R000049723 |
Scientific Title | long year trend of successfully Helicobacter pylori eradicated patients by using vonoprazan: Single center cohort study |
Date of disclosure of the study information | 2021/12/07 |
Last modified on | 2023/07/08 15:03:37 |
long year trend of successfully Helicobacter pylori eradicated patients by using vonoprazan: Single center cohort study
long year trend of eradicated patients
long year trend of successfully Helicobacter pylori eradicated patients by using vonoprazan: Single center cohort study
long year trend of eradicated patients
Japan |
Chronic gastritis
Hepato-biliary-pancreatic medicine |
Malignancy
NO
The purpose of this study is to describe epidemiological information on post-eradication trends in patients treated with vonoprazan for H. pylori eradication.
Safety,Efficacy
long term incidence of gastric cancer and mortality
Observational
20 | years-old | <= |
100 | years-old | >= |
Male and Female
Patients who underwent H.p. eradication with vonoprazan between January 2015 and December 2017 in our hospital will be included.
Patients who are judged by the principal investigator to be unsuitable as subjects or whose consent cannot be obtained.
1000
1st name | Takeshi |
Middle name | |
Last name | Yasuda |
Asahi University Hospital
Department of gastroenterology
500-8523
3-23, Gifu city, Hashimoto
058(253)8001
t-yasuda@koto.kpu-m.ac.jp
1st name | Takeshi |
Middle name | |
Last name | Yasuda |
Asahi University Hospital
Department of gastroenterology
500-8523
3-23, Gifu city, Hashimoto
058(253)8001
t-yasuda@koto.kpu-m.ac.jp
Asahi University
Asahi University
Other
Asahi University Hospital
3-23, Gifu city, Hashimoto
058(253)8001
t-yasuda@koto.kpu-m.ac.jp
NO
朝日大学病院
2021 | Year | 12 | Month | 07 | Day |
Partially published
934
2022 | Year | 06 | Month | 23 | Day |
The average age was 57.8, Sex Male: Female=535:399, Background mucosa; closed type: open type=365: 551 (unknown,:18)).
Minor side effects (e.g. rash, diarrhea, et al) occurred in 3.0% patients.
Among background factors, age, atrophic border was related to the eradication rate. 12 GCs was found after eradication and all cases were stage IA. The 3year and 5year incidence rate was 0.38%, 1.92% respectively. The GCs developed 40.5. months after eradication. 12 people died during the observed period.
No longer recruiting
2018 | Year | 05 | Month | 25 | Day |
2018 | Year | 05 | Month | 25 | Day |
2018 | Year | 05 | Month | 25 | Day |
2030 | Year | 03 | Month | 31 | Day |
retrospective cohort study
2021 | Year | 12 | Month | 07 | Day |
2023 | Year | 07 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049723
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |